Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
See Latest ArticlesImmunohistochemical analysis of P53 and bcl-2 in benign and malignant salivary glands tumors
Journal of Oral Pathology and Medicine, 09/17/09
AL–Rawi et al. – All malignant tumors expressed P53, with the highest record in low–grade adenocarcinoma and the lowest score was observed in both low–grade carcinoma in PA and adenocystic carcinoma. bcl–2 immunostaining was also assessed, the highest recorded score was in high–grade adeno cystic carcinoma and the lowest in both low–grade carcinoma ex–PA and low–grade cystic mucoepidermoid carcinoma. P53/bcl–2 immunostaining reactivity could be helpful in demonstrating salivary glands tumor behavior in terms of progression and extent of invasion.
Today in Salivary Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer
Cancer, 11/25/09
Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09
Clinicopathologic similarities between Mikulicz disease and Kuttner tumor
American Journal of Otolaryngology, 11/04/09
Article Search
Sponsor